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Summary 
Studies with different strains of Syrian hamsters and Syrian golden hamsters have revealed the remark- 
able potential of islet cells to undergo rthotopic and heterotopic metaplasia. The most common sponta- 
neous change included the development of hepatocytes in aged and malnourished hamsters. Of the many 
other alterations that occurred uring carcinogenesis, most of the metaplastic changes originated within the 
islet periphery and progressed inside and outside the islets. The development of ductular structures within 
islets and their progression either to structures identical to human serous cystadenoma or to highly invasive 
adenocarcinomas were the most common alterations. The remarkably greater invasive potential of cancer 
cells arising within the islets contrasted sharply with the slow growth of the tumors developing within ducts 
(intraductal tumors). Studies in human tissue also showed evelopment of malignant cells within islets, and, 
in some cases, transition of islet cells to malignant cells was suggested. The overall results, along with recent 
findings in other studies in cultured human and hamster islets, indicate the enormous potential of islet cells 
to differentiate and undergo malignant transformation. Whether the metaplastic and malignant cells derive 
from stem cells embedded within islets or from transdifferentiated islet cells remains to be seen. 
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Introduction 
The endocrine pancreas till presents a physio- 
logical, biological, and pathophysiological puzzle. 
Although its derivation from endoderm has been 
accepted, its embryological and postfetal develop- 
ment, and macro- and microdomains are poorly 
understood. Its fairly consistent distribution within 
the exocrine pancreas of all mammals and its remark- 
ably similar size, which is in most mammals inde- 
pendent of the body size, reflect a global effect of 
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islets and their unique physiological role. The spe- 
cific spatial distribution of individual hormone- 
producing cells within islets, the cell heterogeneity, 
species differences in the cellular arrangements, and 
their paracrine interaction have remained amystery, 
as have the differences in its cellular composition in 
tissues derived from the ventral and dorsal pancre- 
atic anlage. The production of known and yet some 
unknown hormones by individual cells and the syn- 
thesis of several agonistic or antagonistic hormones, 
even in the same cell (i.e., insulin and amylin), add 
to the physiological complexity of the islets. 
As early as 1927, Neurbert et al. (1) reported on 
the presence of two types of islets in humans. One 
completely separated from the surrounding tissue 
and the other intimately connected with the exocrine 
cells. AltJ~ough the existence of an intimate dialog 
between the endocrine and exocrine pancreas has 
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been recognized, the magnitude of this interaction 
and its mechanisms are unclear. It has been gener- 
ally accepted that the renewal of islet cells occurs 
primarily from ductal/ductular cells. However, the 
molecular mechanism of this event is unclear. The 
questions regarding whether islet cells originate from 
mature ductal/ductular cells or from undifferenti- 
ated (reserve, stem) cells residing within the ductal 
epithelium has not been answered. The pioneer work 
of Bencosme, Boquist, Lazarus and Volk, and Ferner 
and Laidlaw (2-6) has demonstrated the presence 
of a heterogenous cell population within the islets. 
According to their work, islet cells originate from 
undifferentiated cells termed variously as "Helle 
Zellen" (5), islet cell precursors (2), or nesidio- 
blasts (6). 
Histor ical ly ,  the first anatomical  signs for 
endocrine-exocrine i teraction were recognized by 
Bensley in 1911 (7), who by using a meticulous tech- 
nique showed that some islets of Guinea pigs are 
pierced through by ductules and that the ductular 
cells within islets have close contact with islet cells. 
This finding was ignored possibly because the obser- 
vation did not fit with the existing concept at that 
time, when ectodermal origin of islets was favored. 
Bloom and Fawcet, in 1968 (8), confirmed Bens- 
ley's finding in humans, as we did in 1978 in Syrian 
golden hamsters (9). Although in hamsters, the 
"intrainsular" ductules were not present or visible 
in healthy animals, they developed in aged hamsters 
and were particularly dominant in animals treated 
with pancreatic arcinogens (9-11). 
During 24 years of pancreatic ancer research 
using animal models and human tissues, we have 
accumulated ata suggesting the existence of a 
pluripotent cell population within the islets capable 
of producing not only endocrine and exocrine cells, 
but also heterotopic cells of hepato-gastrointestinal 
origin. In the following, the many changes of islet 
cells in Syrian hamsters and in humans are summa- 
rized and discussed. 
Materials and Methods 
Pancreatic tissues derived from our studies were 
used to investigate spontaneous diseases in four 
strains of Syrian hamsters, golden, yellow, white, 
and albino (12), and from several carcinogenicity 
experiments with N-nitrosobis(2-oxopropyl)amine 
(BOP). Human pancreatic tissues were obtained from 
previously reported studies (10,13-16). The tissues 
were fixed either in Bouin solution or in buffered 
formalin, and processed for histology according to 
conventional methods. From a few pancreatic tis- 
sues, frozen sections were prepared for demonstra- 
tion of glycogen. Each hamster pancreas was cut 
See art on facing page 
Fig. 1. The pancreas of a 65-week-old Syrian golden hamster is showing single eosinophilic ells with an abundant 
cytoplasm in the periphery of an islet (arrowheads). (H&E x 210). 
Fig. 2. An islet of a white Syrian hamster with a group of "hepatocytes (arrows)." A portion of another islet, par- 
tially replaced by the hepatocytes, i  seen at the lower left corner. (H&E x 210). 
Fig. 3. Two islets of a Syrian hamster t eated with selenium and a high-fat diet. Almost complete replacement of the 
islet cells by the hepatocytes. Some hepatocytes were reactive with antisomatostatin (i set). H&E • 190. Inset: anti- 
somatostatin, ABC method x 190. 
Fig. 4. A mixture of hepatocytes and glandular structures in the pancreas of an aged Albino Syrian hamster. Note 
formation of glandular structures by the hepatocytes (*) (H&E x 130). 
Fig. 5. Hepatocytes occupying afairly large area of the pancreas of an aged yellow Syrian hamster. Immunohisto- 
chemistry shows remnants of islet cells (black). (H&E • 130). 
Fig. 6. Fat droplets within hepatocytes surrounded by lipocytes. Gradual transformation f hepatocytes to fat cells 
was seen in many areas. Albino Syrian hamster (H&E x 250). 
Fig. 7. Cells resembling oncocytes have replaced three adjacent islets (I). Immunohistochemistry revealed the pres- 
ence of a few [3 cells within the lesion. A BOP-treated Syrian golden hamster (H&E • 120). 
Fig. 8. Cells with ground glass appearance within an islet of a BOP-treated Syrian golden hamster. Note the impres- 
sion of the gradual transformation f islet cells to other cells (H&E • 210). 
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into 6- 12-step sections, and those of humans into 
300-3200 sections. Sections were stained with hema- 
toxyllin and eosin and, in some cases, also with anti- 
bodies against islet hormones or by histochemistry 
for demonstration f amylin and glycogen. 
Results 
By comparing the spontaneous disease of the pan- 
creas in four strains of Syrian hamsters, we observed 
large eosinophilic ells resembling hepatocytes in
aged hamsters, particularly more common and 
prominent in the White strain (12). These hepato- 
cyte-like cells appeared initially in the peripheral 
zone of islets as a single or a small group of cells 
(Fig. 1). From there, they progressed inside the islets 
(Fig. 2) to form spherical conglomerates corre- 
sponding to the size of affected islets with a few or 
no islet cells in the center of the conglomerates (Fig. 
3). Often, several neighboring islets and/or islets in 
dif ferent pancreat ic  regions were affected. In 
advanced cases, the alteration extended into sur- 
rounding pancreatic areas and involved the epithe- 
lium of ductules or formed, per se, glandular 
structures (Fig. 4). Between these cells, scattered 
islet cells could be identified immunohistochemi- 
cally (Fig. 5). In a few cases, some of the hepato- 
cyte-like cells reacted with antisomatostatin (Fig. 
3), but not with antibodies against insulin and 
glucagon. Remarkably, the appearance ofthese cells 
always coincided with lipomatosis of the pancreas. 
Like hepatocytes in fat-liver disease, these cells 
accumulated fat droplets and culminated in cells 
indistinguishable from the surrounding lipocytes 
(Fig. 6). 
Although the development ofhepatocytes is eem- 
ingly a degenerative process, we observed other meta- 
plastic changes that occurred only in hamsters treated 
with the pancreatic carciogen BOR Like hepatocytes, 
cells resembling oncocytes developed in the islet 
periphery and ultimately occupied the whole islet or 
several neighboring islets (Fig. 7) with only a few 
remnant intact islet cells detectable within them. 
In some experiments, especially in those where 
formation of new islets (nesidioblastosis) was stim- 
ulated before BOP treatment (17), a fairly large spec- 
trum of metaplastic changes could be seen. Formation 
of cells with a ground-glass appearance was one of 
these changes (Fig. 8). In these lesions, gradual trans- 
formation of islet cells to the metaplastic cells was 
suggested (Fig. 8). Other metaplast ic hanges 
included clear cells (Fig. 9), mucinous cells (Fig. 
10), goblet-like cells, cells with opaque-appearing 
cytoplasm (Fig. l 1), or a combination of above. The 
opaque cells forming small glandular structures were, 
in some cases, separated from each other by amy- 
loid-like material (Fig. 11) not reactive with the rel- 
ative staining procedures. All of these lesions also 
appeared first in the islet periphery. In the atrophic 
region of the pancreas, owing to ductal obstruction, 
single or multiple cysts lined by various cell types 
were also observed (Fig. 12). 
See art on opposite page 
Fig. 9. Small glands lined by clear cells at the periphery of a BOP-treated Syrian golden hamster. Close to this islet, 
several ductular structures were replace by the clear cells (H&E x 210). 
Fig. 10. A mixture of goblet-like and cuboidal cells forming a large cyst within an islet of a BOP-treated hamster. 
The remnant of islet cells are seen (I) (H&E x 210). 
Fig. 11. Irregular glandular structures separated by bands of hyaline-like material. No evidence for amyloid depo- 
sition could be found. This lesions was confined to one islet. A BOP-treated hamster (H&E x 210). 
Fig. 12. A large cyst lined by fiat or cuboidal cells within an islet in the atrophic pancreatic region of a BOP-treated 
hamster. This hamster had a large cancer in the head of the pancreas (H&E x 210). 
Fig. 13. Tiny ductular structures (arrow) within an enlarged islet of a hamster treated with BOP. This was the only 
alteration found in the pancreas of this hamster (H&E x 165). 
Fig. 14. Ramified and distended uctular structures with an islet of a BOP-treated hamster. There were no other 
lesions identifiable (H&E • 65). 
Fig. 15. Formation of microcystic structures within several neighboring islets and in their surrounding tissues, giving 
the impression of human microcystic adenoma (H&E x 110). 
Fig. 16. A multicystic lesion in the pancreas of a hamster treated with BOP. The encapsulated lesion is comparable 
to human serous cystadenoma (H&E x 65). 
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The most striking and consistent changes in BOP- 
treated hamsters were the development of ductular 
structures within islets. These changes occurred 
much earlier than any other alterations in the ductal 
system. Initially, the tiny, difficult-to-discern chan- 
nels developed at the periphery or the center of islets 
(Fig. 13). At later stages, these channels expanded, 
ramified, and formed complex structures that grad- 
ually occupied the entire islet (Fig. 14) and culmi- 
nated in microcystic or macrocystic patterns 
consistent with human serous cystadenomas (Figs. 
15 and 16). In other islets, the intrainsular ductular 
cells appeared hyperplastic from their inception (Fig. 
17), atypical (Fig. 18), or malignant, occupying part 
of or the entire islets, and invading the surrounding 
tissue even at their microscopic size (Fig. 19). In 
hamsters treated with high doses of the carcinogen, 
a single or a small group of pleomorphic malignant 
cells forming bizarre glandular structures appeared 
at early carcinogenesis process (Figs. 20 and 21). 
Electron microscopical examination fsuch a lesion 
showed that ductular structures contained scattered 
neuroendocrine granules (Fig. 22). 
The differentiation pathway of islet cells seems 
to be altered in pathological conditions, particularly 
in response to carcinogens, including streptozotocin. 
This diabetogenic and carcinogenic compound selec- 
tively destroys the [3-cells in many species and leads 
to a peculiar honeycomb pattern of islets owing to 
swelling and glycogen accumulation i  the 13-cells 
(Fig. 23). In animals recovering from diabetes, pleo- 
morphic and bizarre cells develop in the periphery 
of islets (Fig. 24), and give rise to tumors of various 
cellular composition (18), adding to the spectrum of 
phenotypic displays of islets. 
The described islet alterations and other confir- 
matory findings not included in this article show that 
in hamsters most pancreatic tumors of endocrine or 
exocrine phenotype, arise from within islets. There- 
fore, it is ironic to see that the endocrine pancreas 
"gives birth" to exocrine pancreatic cancer. Anec- 
dotal observations indicate the situation is not dif- 
ferent in humans. 
Following our experimental observation, we paid 
particular attention to the islets of patients with pan- 
creatic ancer and by evaluating more than 3200 sec- 
tions/pancreas could confirm Warren's finding (41). 
As in hamsters, intrainsular ductules could be found 
in patients with pancreatic diseases, especially 
chronic pancreatitis and pancreatic cancer (Fig. 25), 
but malignant cells have been identified only in 
patients with pancreatic ancer. Strikingly, these 
lesions, also developed in the islet periphery (Fig. 
26), were present not only in the vicinity of cancers, 
but also in the tail of the pancreas, very remote from 
the primary cancers in the pancreas head (10,24). As 
illustrated in Figs. 26 and 27, no connection could 
be found between the malignant intrainsular cells 
and the surrounding tissue, which in most cases was 
fibrotic or scarred. As in the hamster model, small 
groups of malignant cells forming abortive glandu- 
lar structures were also found in areas free of cancer 
(Figs. 28 and 29). In two pancreatic cancer patients 
with atrophic and scarred tail portions of the 
pancreas, the fragmented islets were abruptly inter- 
rupted by a single or small groups of malignant cells. 
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Fig. 17. Tiny ductular structures with hyperplastic ducts found during early stages of carcinogenesis within an islet. 
Note the hepatocytes in the islet periphery (arrow) (H&E • 65). 
Fig. 18. Atypical ductular structures with hyperplastic epithelium replacing most of the islet cells (I) (H&E x 190). 
Fig. 19. Malignant ductular structures within an islet invading the surrounding tissue in a BOP-treated hamster (H&E 
x 190)o 
Fig. 20. A few, malignant-appearing cells within a small hamster islet forming a minute lumen (*) (H&E x 210). 
Fig. 21. A malignant gland within a small islet of a BOP-treated hamster (H&E x 210). 
Fig. 22. Electron microscopical finding of a well-differentiated pancreatic cancer showing focal accumulation of
neuroendocrine-like granules (arrowheads) (x 3500). 
Fig. 23. Pancreatic islet of a hamster treated with streptozotocin. Ballooning of many islet cells. Frozen section 
demonstrated glycogen within the empty-looking cells (H&E x 210). 
Fig. 24. An islet of a hamster treated with streptozotocin 20wk earlier. Note atypical pleomorphic cells occupying 
almost onehalf of the islet (H&E x 210). 
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Many islets also showed a pattern suggesting rad- 
ual transformation of islet cells into malignant cells 
(Fig. 30). 
Other noteworthy alterations of islets in pancre- 
atic cancer patients included the expression of tumor- 
associated antigens (TAG72, CA 19-9, DU-PAN-2) 
and loss of immunoreactivity o antihormone anti- 
bodies in islets close to or remote from cancers (Figs. 
31 and 32). Some of these islets were partially or 
completely replaced by ductular structures, the cell 
linings of which expressed the same antigen (Figs. 
31 and 32), indicating that either islet cells trans- 
differentiate into ductular phenotype or the differ- 
entiation pathway of islet precursor cells has been 
switched into the ductal cell lineage. 
Discussion 
The plasticity of ductal cells to undergo a spec- 
trum of metaplastic changes has been observed by 
many investigators, especially in tumors that sup- 
posedly originated from ductal cells (19). Accord- 
ing to Feyrter, the switch in the differentiation 
pathway is inherent o acinar cells also, which may 
even give rise to islet cells (20). However, the abil- 
ity of islet cells to differentiate into exocrine cell lin- 
eage was recognized much later and was initially 
found to be limited to the formation of amphicrine 
cells containing both neuroendocrine granules and 
mucin (21-23). Although intermediary cells have 
been observed in the pancreas of many species, 
including humans (24), the overall concept was that 
they develop from pancreatic stem cells through a 
dual differentiation pathway. 
We have found that at least in the hamster, that 
the potential of islet cells to undergo metaplastic 
changes is as great as that of ductal cells. The most 
common phenotypic hange in untreated hamsters 
were differentiation toward hepatocyte cell lineage. 
Our original observation was later confirmed by 
Scarpelli and Rao, who found the same lesions in 
younger  hamsters  treated with the pancreat ic  
carcinogens (25) and showed that these cells were 
morphologically and biologically identical to hepa- 
tocytes. They also found that these "pancreatic hepa- 
tocytes" can be induced in a copper-depleted diet in 
hamsters and rats (26). Cadmium chloride in rats 
could produce the same lesion (27). All these obser- 
vations suggest malnutrition as an etiological factor. 
Remarkably ,  s imi lar cells have been observed 
recently in human fetal pancreas (28), indicating that 
this change is not restricted to animals. 
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Fig. 25. A bottle-shaped intrainsular ductular structure in a patient with chronic pancreatitis (H&E x 110). 
Fig. 26. Malignant cells in the periphery of several neighboring islets embedded in fibrotic stroma in the pancreas 
tail. Note the tumor free periinsular region (H&E x 65). 
Fig. 27. An islet in the tail of the pancreas of a 72-yr-old man with cancer in the head of the pancreas. The sur- 
rounding tissue was scarred, and there were no tumor cells around. Note the arrangement of cancer cells along the islet 
periphery. Part of another altered islet in the upper left comer (H&E x 165). 
Fig. 28. Small atypical glandular structures within two adjacent islets. Although the cells lining the gland in the right 
islets resembles i let cells, the tumor cell in the left islet are long and bridges eparated islet cell groups (H&E • 210). 
Fig. 29. A malignant gland in the periphery of an islets in the scarred tail of the pancreas in a 68-yr-old male with a 
2.5 mm cancer in the head region. Apparent ranstion of islet cells to malignant cells (H&E x 210). 
Fig. 30. Fragmented islets in the atrophic tail of the pancreas of a 65-yr-old man with a cancer in the body-head 
region. The step sections did not reveal any connections between these lesions and the cancer. Note apparent replace- 
ment of islet cells by malignant cells with formation of a ductular structure (*) and the presence of a few atypical cells 
within an islet (arrowhead). The continuation of some islets was interrupted by a single or small group of cancer cells 
(arrow) (H&E x 210). 
Fig. 31. An islet in a 53-yr--old male with a cancer in the pancreas body. Note the presence of an intrainsular ductu- 
lar structure, the cells of which are stained (black) with anti-DU-PAN-2 antibody. The same reactivity is seen in a few 
islet cells and in cancer cells around the islet. ABC method (• 
Fig. 32. A Strong immunoreactivity of many islet cells (left and middle) and cancer cells (right) with anti-CA 19-9 
antibody. Note the formation of a glandular structure within the small islet (*). ABC method (x 210). 
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A wide spectrum of phenotypical changes of islet 
cells observed in BOP-treated hamsters were similar 
to those found in benign and malignant lesions of ductal 
cell origin. Many heterotropic phenotypes, including 
oncocytes and clear cells, have been found in human 
pancreatic lesions. Oncocytes are characterized bythe 
epithelial cell, the cytoplasms ofwhich are filled with 
mitochondriae that in the routine H&E preparations 
give the cells a fine granular appearance. These cells 
have been described in hyperplastic and neoplastic 
human islets (29), in human ductal epithelium (30), in 
papillary-cystic umors (31), or as oncocytoma com- 
posed entirely of oncocytes (32,33). Similarly, tumors 
of clear-cell character have been observed occasion- 
ally in human pancreatic cancers (34). 
A consistent change in the pancreas of BOP- 
treated hamsters was formation of benign and malig- 
nant ductular structures within islets. The origin of 
these structures from cells within the islets has been 
convincingly illustrated in cultured islets. In these 
cultures, the initially pure human and hamster islets 
tree of intrainsular ductular components formed not 
only cells of ductular phenotype but also acinar, inter- 
mediary, and oncocyte cells shortly after culturing 
(35). Development of ductules within cultured 
human islets have also been reported (36-38). These 
data point o the pluripotent ature of some cell com- 
ponents within islets, possibly representing islet pre- 
cursor cells (2-4), Helle ZeUen (5), reserve cells, or 
nesidioblasts (6). However, transdifferentiation of 
islet cells to exocrine cell phenotype has also been 
suggested (37). 
Formation of malignant ductular (glandular) struc- 
tures within islets is of particular interest, because 
it is generally believed that pancreatic ancer of 
ductal morphology arises from ductal epithelium. 
The development of tumors initially within islets 
before any ductal alterations indicates that he reserve 
(stem) cells within the islets are more vulnerable to 
malignant transformation than the cells within ductal 
epithelium. It is also possible that the intrainsular 
lesions have a growth advantage because of their 
direct exposure to growth factors produced by islet 
cells. This possibility was validated in one of our 
most recent studies. When we transplanted freshly 
isolated hamster islets into the submandibular gland 
(a nontarget tissue of BOP) of recipient hamsters, 
highly invasive and metastatic cancers originating 
from islets developed 4 wk after BOP treatment (39), 
the shortest latency of pancreatic cancer ever pro- 
duced. In the hamster pancreas, the same dose of the 
carcinogen produces equivalent cancers no earlier 
than 20 wk (10). The significantly faster growth of 
tumors within the submandibular gland than in the 
pancreas could have been owing to the additional 
growth-promoting effect of epidermal growth factor 
within this gland. Nevertheless, the rapid growth and 
invasive potential of the intrainsular ductular struc- 
tures contrast sharply with the late development and 
slow growth of lesions developing within the ductal 
system. Morphologically and biologically, these 
intraductal tumors are almost identical to human 
intraductal (papillary, mucinous) tumors (40). Dif- 
ferences between the intrainsular and intraductal 
tumors do not indicate etiological differences, at 
least in hamsters, but rather differences in the loca- 
tion of the tumors that may dictate tumor cell growth. 
Nevertheless, in the hamster model, where the 
progression of tumors can be adequately examined, 
most pancreatic cancers develop within islets. Warren 
seems to have been the first to observe the develop- 
ment of malignant cells within islets in 1938 (41). 
This finding was either ignored or was interpreted 
as invasion of islets by cancer cells. Our anectodal 
observations indicate that this is also the case with 
human pancreatic ancer. The initial development 
of cancers within human islets was demonstrated in 
one of our recent studies. In two patients who died 
of gastric or renal cancer, we observed two micro- 
scopic cancers (2.6 x 0.7 and 4 x 2 mm) at autopsy 
in the body of the pancreas. In both cases, cancer 
cells were primarily located within islets and 
extended into the periinsular areas invading the 
nerves (42). Similar to most pancreatic cancers, both 
of these microscopic lesions showed the mutation 
of the c-Ki-ras oncogene and expressed pancreatic 
cancer-associated antigens. Therefore, it is very 
likely that at least some human pancreatic cancers 
develop within islets. 
Our observations along with studies on pancre- 
atic endocrine and exocrine tissue let us assume that 
tumors, regardless of their phenotype, derive from 
pancreatic reserve (stem) cells, which are obviously 
distributed along the ductal system and within the 
islets. This concept best explains the occurrence of 
pancreatic tumors composed of mixed ductal- 
insular cancers (43-51) (Fig. 29), even in their 
metastatic sites (50). 
Our data show that some components ofislets are 
highly pluripotential nd on pathological stimula- 
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tion, give rise to a wide spectrum of orthotopic and 
heterotopic cells in animals and humans. Although 
many metaplastic changes in hamster islets have not 
been seen in the human pancreas, tumors composed 
of similar or identical cell phenotypes occur in some 
human pancreatic tumors. Because the lesions in 
hamsters are seen mostly during early stages of car- 
cinogenesis, are multifocal, and can be observed 
often in one of the serial sections of the whole pan- 
creas, their apparent absence in humans is self- 
explanatory. 
The insular cells from which the exocrine cells 
originate is obscure. Although the transdifferentia- 
tion of mature islets to other cell types has defend- 
ers (reviewed in 35,37,38), considering the spectrum 
of cells of gastrointestinal origin produced within 
islets, the stem cell theory is more likely. The expres- 
sion of fetal antigens in pancreatic tumors, includ- 
ing CEA, c~- 1 antitrypsin (52), and c~- fetoprotein (53), 
supports this notion. It is noteworthy that most of the 
metaplastic cells initially develop in the islet periph- 
ery where normally islet replication takes place. 
Therefore, it is tempting to assume that periinsular 
ductular cells are the origin of these cells. However, 
as described above, in many cases, the lesions were 
within the boundary of islets, and no traces of peri- 
insular ductules could be found, or if present, no con- 
nection to the insular tissue was evident. 
Consequently, some cells in the islet periphery seem 
to be more responsive to phenotypic changes than 
the cells in other pancreatic regions. The identity of 
these cells is unclear at the present time. 
It appears that the differentiation state of pancre- 
atic cells is mainly controlled at the transcriptional 
level and involves repression of islet cells and upreg- 
ulation of ductal or acinar cell genes, and perhaps 
repres, ion of ductal and upregulation of islet cells. 
Seemingly, this "genetic switch" is more active in 
islet cells than in the exocrine ceils. The recent iden- 
tification of transcriptional factors involved in the 
differentiation f pancreatic cells, and especially of 
islet ceils (54) could help the understanding of the 
1000 faces of islets. 
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